Phase 2 biotech developing an oral small molecule therapy for chronic cough.
Industry: Health Care
First Day Return: +0.1%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/03/2019 |
Offer Price | $7.10 |
Price Range $7.10 - $7.10 | |
Offer Shares (mm) | 9.9 |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 09/05/2019 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $70 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | Quebec, Canada |
Founded | 1993 |
Employees at IPO | 12 |
Website www.bellushealth.com |